Mark W. Kroll
CIK: 0001259254
Transaction Breakdown
Open Market Buys (P)1 (33.3%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
HAE
HAEMONETICS CORP
Director
Discretionary Trading P&L
Holdings
About KROLL MARK W
KROLL MARK W (SEC CIK 0001259254) files insider reports with the SEC as Director of HAEMONETICS CORP (HAE).
Signal8 holds 3 ownership filings by KROLL MARK W, all Form 4s, filed between Jul 25, 2025 and Jul 28, 2026. Those filings report 3 transactions, from Jul 24, 2025 to Jul 24, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on KROLL MARK W's filings is in BOSTON, MA.
Recent filings by KROLL MARK W
Other insiders filing for HAEMONETICS CORP (HAE)
- Madaus Martin D, Director
- Zane Ellen M, Director
- Pomeroy Claire, Director
- Johnson Lloyd Emerson, Director
- COYLE MICHAEL J, Director
- Bryant Diane M, Director